ThalesNano Announces the Launch of H-Cube Midi(TM), its Next Generation Hydrogenation Technology Product Applicable for Process Development



    BUDAPEST, Hungary, PRINCETON, NJ and LONDON, Oct. 8 /CNW/ - ThalesNano
Inc. announced today that it has launched the latest of its Cube(TM) flow
reactor series, H-Cube Midi(TM). This novel product is now commercially
available and validated with several important chemistry applications.
    The H-Cube Midi(TM) is designed to fulfill the requirements of process
scale flow hydrogenation. Based upon the current H-Cube(R) technology
platform, the H-Cube Midi(TM) is designed to increase the capacity of the
present H-Cube(R) up to kg quantities per day without compromising efficiency
and safety.
    Dr. Laszlo Urge, CEO of ThalesNano commented: "H-Cube Midi(TM) was
designed in response to increasing customer needs to be able to scale up
reactions optimized on H-Cube(R). Several pharmaceutical companies have
adopted H-Cube(R) as the first choice for hydrogenation in discovery. As
compounds move from discovery to development, there is a need to increase the
scale up to kg levels as fast as possible. The H-Cube Midi(TM) allows the
optimization and transition from mg scale to kg levels to be performed within
a day. The increase in productivity and the savings in cost and time are
expected to be significant for those R&D organizations who have adopted this
technology."
    "The launch of this new product underlines that we are executing a
complex strategy and building a product portfolio in the flow chemistry area.
Our product development strategy is designed to provide integrated continuous
flow solutions from discovery to full scale production and could help solve
some of the bottlenecks in the pharmaceutical and chemical industries," stated
Dr. Ferenc Darvas, President and Chairman at ThalesNano.
    For more information please refer to ThalesNano's website at
http://www.thalesnano.com/

    About ThalesNano:

    ThalesNano is a technology-intensive company that provides chemical
Solutions in discovery, process development and production for pharmaceutical
And chemical companies. The Company specializes in developing and providing
microscale flow instruments for chemistry, by exploiting the benefits of
combining micro- and meso-fluidics and nanotechnology with flow chemistry.
    The award winning development, H-Cube(TM), has been recognized as one of
the 100 most technologically significant and innovative new products of 2005
by R&D Magazine and is the first in a new wave of continuous-flow
hydrogenation reactors. Utilizing water electrolysis to generate hydrogen,
with a catalyst cartridge system and with a continuous-flow reactor, the
shoe-box sized H-Cube(TM) makes hydrogenation convenient, more efficient and
less hazardous. With this equipment, reactions that are extremely challenging
to carry out with traditional methods can be performed. These products are
already on the market and utilized by 18 of the top 20 pharmaceutical
companies in the world.





For further information:

For further information: Laszlo Urge, CEO, e-mail:
titkarsag@thalesnano.com, Telephone: +36-1-880-8500

Organization Profile

THALESNANO NANOTECHNOLOGY INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890